Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Lilly Announces Top-Line Phase 3 Results for Baricitinib Trial

americanpharmaceuticalreviewFebruary 19, 2019

Tag: Lilly , Baricitinib Trial , BREEZE , AD

PharmaSources Customer Service